Singapore, September 16, 2026.
SINGAUTO’s licensed commercial partner has entered into an agreement to develop and deliver a custom-engineered Level 4 (L4) autonomous cold-chain electric vehicle for deployment at a global biopharmaceutical manufacturing facility.
The project has progressed into the production phase, with manufacturing and initial on-site installation currently targeted for completion by the end of 2026, followed by on-site commissioning, validation and acceptance in 2027.
The agreement calls for a purpose-built vehicle designed to move temperature-sensitive materials within the designated facility premises, combining L4 autonomous driving, precision temperature control and integrated data traceability in a single platform.
“Cold-chain integrity isn’t just a compliance requirement in pharmaceutical operations — it’s mission-critical,” said a SINGAUTO spokesperson. “This project reflects growing demand for advanced cold-chain transportation solutions in environments where consistency, safety and traceability are essential, and we’re proud to be contributing a purpose-engineered solution designed to meet those requirements.”
Cold-Chain Logistics in Controlled Facility Environments
Cold-chain logistics plays an essential role in preserving the quality and integrity of temperature-sensitive products. Within pharmaceutical operations, internal transfers between storage, production and quality-control areas require consistent temperature management, carefully coordinated handling and reliable operational records — requirements that make advanced cold-chain transportation solutions particularly valuable.
In designated and controlled environments, autonomous cold-chain vehicles have the potential to enhance the consistency of transport processes while reducing reliance on repetitive manual movement.
Engineered for the Pharmaceutical Environment
Solutions for pharmaceutical operations require more simply combining refrigeration, transportation and monitoring technologies. System reliability, temperature performance, route design, operating procedures, safety controls and data integrity all have to be engineered together and validated against the demands of the intended environment. SINGAUTO’s approach brings these disciplines — vehicle engineering, L4 autonomous driving, temperature-control systems and digital monitoring — into a single, purpose-built platform.
Temperature management. A dedicated temperature-control system is engineered to maintain stable conditions throughout internal transfers.
Level 4 autonomous driving. The vehicle’s L4 autonomous driving capability is intended to support operation within defined, controlled facility environments shared with authorized personnel and other equipment, supporting repeatable and consistent driverless vehicle movements within its defined operating environment.
Data traceability. Integrated monitoring and data-recording functions give operators visibility into vehicle location and temperature conditions throughout every transfer.
From Contract to Production
Since the agreement was signed, the project has progressed from design into vehicle production. Manufacturing and delivery to the designated facility are currently targeted for completion by the end of November 2026, followed by on-site installation by the end of 2026. Commissioning, validation and final acceptance are expected to take place in 2027, subject to the completion of the relevant development, manufacturing and testing milestones.
The project highlights the growing demand for advanced cold-chain transportation solutions in controlled industrial environments and may support future applications across other highly regulated industries.
About SINGAUTO
Headquartered in Singapore, SINGAUTO is a green intelligent cold-chain technology company focused on developing refrigerated commercial electric vehicles and related solutions for customers in the cold-chain logistics industry, including transportation and logistics service providers serving food products, pharmaceuticals and other temperature-sensitive goods.
This press release contains forward-looking statements within the meaning of the U.S. federal securities laws, including statements regarding anticipated vehicle delivery timelines, product capabilities and future business plans. These statements are based on current expectations and assumptions and are subject to risks and uncertainties that could cause actual results to differ materially, including delays in manufacturing, testing or validation. SINGAUTO undertakes no obligation to update these statements except as required by law.